Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Standard Bupivacaine for Abdominoplasty
NCT01853176Phase 4Terminated
- Sponsor
- Emory University
- Start
- May 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Emory University. Primary endpoint: Visual Analogue Pain Scores at 3 days. Started May 2013; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01853176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853176.